1887

Abstract

An antiviral effect of prostaglandins (PGs) of the A series on the replication of human immunodeficiency virus (HIV) has been determined. In the T cell line C8166 under single growth cycle conditions, PGA reduced the number of infectious progeny 1000-fold in the absence of cytotoxicity. Thus, inhibition of HIV replication by PGA represents a true antiviral phenomenon. The number and size of virus-induced syncytia, and the amount of viral antigen were also drastically reduced. The effect was specific for PGAs because PGA was also inhibitory, whereas PGB, PGE and PGE were inactive. Virus adsorption and penetration do not appear to be targets of antiviral action because PGA substantially reduced virus replication, even when added 5 h post-infection. PGA did not inhibit viral reverse transcriptase, as determined by assays, suggesting that its antiviral action is not the consequence of a direct inhibitory effect on this enzyme. PGA also inhibited the replication of HIV-1 in CEM × 174 cells, but with less potency. Previously, intravenous infusion of PGA into human volunteers has shown no significant deleterious side-effects and thus these observations suggest that PGAs might have potential as antiviral agents in humans.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-11-2797
1991-11-01
2022-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/11/JV0720112797.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-11-2797&mimeType=html&fmt=ahah

References

  1. Ankel H., Mittnacht S., Jacobsen H. 1985; Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon. Journal of General Virology 66:2355–2364
    [Google Scholar]
  2. Bader T., Ankel H. 1990; Inhibition of primary transcription of vesicular stomatitis virus by prostaglandin At. Journal of General Virology 71:2823–2832
    [Google Scholar]
  3. Benavente J., Esteban M., Jaffe B. M., Santoro M. G. 1984; Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA1 in vaccinia virus-infected cells. Journal of General Virology 65:599–608
    [Google Scholar]
  4. Denizot F., Lang R. 1986; Rapid colorimetric assay for cell growth and survival. Journal of Immunological Methods 89:271–277
    [Google Scholar]
  5. Dianzani F., Capobianchi M. R., Antonelli G., Amicucci P., De Marco F. 1989; Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction. Antiviral Research 11:299–306
    [Google Scholar]
  6. Kong L. I., Lee S.-W., Kappes J. C., Parkin J. S., Decker D., Hoxie J. A., Hahn B. H., Shaw G. M. 1988; West African HIV-2 related human retrovirus with attenuated cytopathicity. Science 240:1525–1529
    [Google Scholar]
  7. Lee J., Kannegiesser H., O’Toole J., Westura E. 1971; Hypertension and the renomedullary prostaglandins: a human study of the antihypertensive effects of PGA1 . Annals of the New York Academy of Science 180:218–240
    [Google Scholar]
  8. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
  9. Santoro M. G., Jaffe B. M., Esteban M. 1983; Prostaglandin A inhibits the replication of vesicular stomatisis virus: effect on virus glycoprotein. Journal of General Virology 64:2797–2801
    [Google Scholar]
  10. Santoro M. G., Favalli C., Mastino A., Jaffe B. M., Esteban M., Garaci E. 1988; Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus. Archives of Virology 99:89–100
    [Google Scholar]
  11. Santoro M. G., Amici C., Elia G., Benedetto A., Garaci E. 1989; Inhibition of virus glycosylation as the mechanism of the antiviral action of prostaglandin A in Sendai virus-infected cells. Journal of General Virology 70:789–800
    [Google Scholar]
  12. Sodroski J. G., Rosen C. A., Haseltine W. A. 1984; Transacting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381–385
    [Google Scholar]
  13. Westura E. E., Kannegiesser H., O’Toole J. D., Lee J. B. 1970; Antihypertensive effects of prostaglandin A1 in essential hypertension. Circulation Research Supplement I 18:131–137
    [Google Scholar]
  14. Willey R. L., Smith D. H., Lasky L. A., Theodore T. S., Earl P. L., Moss B., Capon D. J., Martin M. A. 1988; In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of Virology 62:139–147
    [Google Scholar]
  15. Yamamoto N., Fukushima M., Tsurumi T., Maeno K., Nishiyama Y. 1987; Mechanism of inhibition of herpes simplex virus replication by Δ7 prostaglandin A1 and Δ12 prostaglandin J2 . Biochemical and Biophysical Research Communications 146:1425–1431
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-11-2797
Loading
/content/journal/jgv/10.1099/0022-1317-72-11-2797
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error